Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals shares soared 24.05 percent on volume of 1.34 million shares traded Tuesday to close at $8.46. The company announced that the FDA has approved Amitiza for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.
Going forward ... (see research report)
Subscribe to News Feeds